Leeds Institute of Rheumatic and Musculoskeletal Medicine
Improving diagnosis, intervention, therapy and outcomes
- Faculty of Medicine and Health
- School of Medicine
- Groups and institutes
- Leeds Institute of Rheumatic and Musculoskeletal Medicine
Leeds Institute of Rheumatic and Musculoskeletal Medicine
Leeds Institute of Rheumatic and Musculoskeletal Medicine
Our world-leading research improves the delivery of care across the spectrum of rheumatic and musculoskeletal medicine.
We deliver a dynamic portfolio of research and education, and our collaborations with the Institute of Medical and Biological Engineering and the School of Dentistry combine our interrelated expertise to address areas such as joint replacements, spinal interventions and oral diseases.
We also work closely with the Leeds Teaching Hospitals NHS Trust as a strategic partner in the Leeds NIHR Biomedical Research Centre.
Leeds Prospective Remission Clinic
Find out more about the Leeds Prospective Remission Clinic and our research in rheumatoid arthritis patients in remission.
This facility is a NHS/Research remission clinic set up in Chapel Allerton Hospital to facilitate research and develop new guidelines for the ongoing management of RA patients in remission.
Gut health signals could transform arthritis treatment
Changes in the gut microbiome before rheumatoid arthritis is developed could…
Friday 8 November 2024
More on Gut health signals could transform arthritis treatmentThe Charterhouse Rheumatism Charity and ongoing research into rheumatology and musculoskeletal medicine.
The Charterhouse Rheumatism Charity (the Charity) was established in 1936 to…
Monday 30 January 2023
More on The Charterhouse Rheumatism Charity and ongoing research into rheumatology and musculoskeletal medicine.New Lancet Rheumatology paper shows low risk of severe outcomes from Rituximab use for patients who receive COVID and Booster vaccination
Patients taking an immunosuppressant drug for rheumatic and musculoskeletal…
Thursday 12 January 2023
More on New Lancet Rheumatology paper shows low risk of severe outcomes from Rituximab use for patients who receive COVID and Booster vaccinationScientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
New research has identified a genetic marker that could be used to predict a…
Monday 9 January 2023
More on Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment